Body mass index and noninfectious comorbidity in HIV-positive patients commencing antiretroviral therapy in Zimbabwe.
J M BleaselJack E HeronT ShamuC ChimbeteteR DahwaD M GraceyPublished in: HIV medicine (2020)
We demonstrate a high prevalence of overweight/obesity and hypertension in an urban cohort of PLWH in Zimbabwe. Higher BMI was associated with a higher CD4 count, both before and 6 months after commencing antiretroviral therapy; it was also associated with loss of renal function in this cohort.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- human immunodeficiency virus
- hiv infected patients
- men who have sex with men
- hiv aids
- hiv testing
- end stage renal disease
- south africa
- weight loss
- weight gain
- chronic kidney disease
- type diabetes
- blood pressure
- ejection fraction
- metabolic syndrome
- newly diagnosed
- prognostic factors
- body mass index
- insulin resistance
- adipose tissue
- physical activity
- hepatitis c virus
- nk cells